Eric Hedrick

Chief Medical Officer

Dr. Eric Hedrick is Chief Medical Officer (CMO) at Lakefront Biotherapeutics. He joined the company in July 2025 and was promoted to CMO in June 2026. Prior to Lakefront, he held roles as Chief Executive Physician at EQRx, Chief Advisor and Interim Chief Medical Officer for BeiGene, Chief Medical Officer at Epizyme and Interim Chief Medical Officer at Pharmacyclics. He holds an MD from the University of Maryland and was an attending physician at Memorial Sloan Kettering Cancer Center. He holds a BA from Boston University.

Eric Hedrick Lakefront Biotherapeutics